First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 107.92 USD 0.79%
Updated: Apr 23, 2024

EBITDA Margin
Abbott Laboratories

24.5%
Current
27%
Average
8.4%
Industry
Positive for the last year
24.5%
Positive average
27%
Worse than average
Better than industry value

EBITDA Margin Across Competitors

EBITDA Margin Comparison
Abbott Laboratories Competitors

Country Company Market Cap EBITDA
Margin
US
Abbott Laboratories
NYSE:ABT
186.6B USD
25%
US
Intuitive Surgical Inc
NASDAQ:ISRG
132.9B USD
31%
US
Stryker Corp
NYSE:SYK
124.7B USD
26%
IE
Medtronic PLC
NYSE:MDT
107.6B USD
28%
US
Boston Scientific Corp
NYSE:BSX
100.6B USD
25%
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD
22%
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR
17%
US
Edwards Lifesciences Corp
NYSE:EW
52.5B USD
32%
US
Dexcom Inc
NASDAQ:DXCM
51.7B USD
22%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
344.1B CNY
36%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
40.6B USD
33%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 186.6B USD
EBITDA Margin
25%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 132.9B USD
EBITDA Margin
31%
Stryker Corp
NYSE:SYK
Country US
Market Cap 124.7B USD
EBITDA Margin
26%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 107.6B USD
EBITDA Margin
28%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 100.6B USD
EBITDA Margin
25%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 67.8B USD
EBITDA Margin
22%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 58.1B EUR
EBITDA Margin
17%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 52.5B USD
EBITDA Margin
32%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 51.7B USD
EBITDA Margin
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 344.1B CNY
EBITDA Margin
36%
IDEXX Laboratories Inc
NASDAQ:IDXX
Country US
Market Cap 40.6B USD
EBITDA Margin
33%

Profitability Report

View the profitability report to see the full profitability analysis for Abbott Laboratories.

Full Profitability Report

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is EBITDA Margin?
What is the EBITDA Margin of Abbott Laboratories?

Based on Abbott Laboratories's most recent financial statements, the company has EBITDA Margin of 24.5%.

ALPHA SPREAD
Join more than 130,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.